| Liver Carcinoma investigated in trials for …INVESTIGATED_IN_TRIALSderived157 of 157show fewer |
|---|
| → investigated in trials for | Sorafenibsmall molecule 178 trials (12 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 178 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lenvatinibsmall molecule 144 trials (65 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 144 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bevacizumabmonoclonal antibody 111 trials (63 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 111 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nivolumabmonoclonal antibody 70 trials (22 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 70 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Atezolizumabmonoclonal antibody 67 trials (44 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 67 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Durvalumabmonoclonal antibody 67 trials (47 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 67 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pembrolizumabmonoclonal antibody 64 trials (19 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 64 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sintilimabmonoclonal antibody 58 trials (28 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 58 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tislelizumabmonoclonal antibody 41 trials (20 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 41 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tremelimumabmonoclonal antibody 37 trials (28 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 37 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cisplatinsmall molecule 35 trials (14 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 35 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gemcitabinesmall molecule 35 trials (15 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 35 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Camrelizumabmonoclonal antibody 34 trials (15 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 34 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cabozantinibsmall molecule 31 trials (15 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 31 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Oxaliplatinsmall molecule 29 trials (9 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 29 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Regorafenibsmall molecule 28 trials (10 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 28 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Toripalimabmonoclonal antibody 26 trials (7 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 26 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Capecitabinesmall molecule 24 trials (8 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 24 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Doxorubicinsmall molecule 24 trials (5 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 24 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipilimumabmonoclonal antibody 23 trials (11 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 23 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cyclophosphamidesmall molecule 20 trials (10 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 20 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fluorouracilsmall molecule 17 trials (5 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 17 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fludarabinesmall molecule 14 trials (5 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sorafenib Tosylatesmall molecule 13 trials (0 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Adebrelimabmonoclonal antibody 12 trials (8 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | FOLFOX Regimen 11 trials (5 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Everolimussmall molecule 9 trials (2 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pegargiminaseother 9 trials (1 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Thalidomidesmall molecule 9 trials (1 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dexamethasonesmall molecule 8 trials (2 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Epirubicinsmall molecule 8 trials (0 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Leucovorinsmall molecule 8 trials (1 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nab-paclitaxel 8 trials (3 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sunitinibsmall molecule 8 trials (2 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Axitinibsmall molecule 7 trials (0 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erlotinibsmall molecule 7 trials (0 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | FOLFOX-4 Regimen 7 trials (1 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ramucirumabmonoclonal antibody 7 trials (0 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carboplatinsmall molecule 6 trials (3 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erlotinib Hydrochloridesmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mitomycinsmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sirolimussmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Irinotecansmall molecule 5 trials (3 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Paclitaxelsmall molecule 5 trials (3 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tegafursmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Immune Checkpoint Inhibitor 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Metforminsmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Palbociclibsmall molecule 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pemigatinibsmall molecule 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Prednisonesmall molecule 4 trials (3 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sapanisertibsmall molecule 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Serplulimabmonoclonal antibody 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Anti-PD1 Monoclonal Antibody 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Arsenic Trioxidesmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Avelumabmonoclonal antibody 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bortezomibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cetuximabmonoclonal antibody 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Chemotherapy 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cixutumumabmonoclonal antibody 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dasatinibsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Derazantinibsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Docetaxelsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Enzalutamidesmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Etoposidesmall molecule 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Hydroxychloroquinesmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Idarubicinsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lenalidomidesmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nintedanibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Temsirolimussmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tivozanibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trametinibsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Akt Inhibitor MK2206 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Aldesleukinother 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Aspirinsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Binimetinibsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Capmatinibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cediranibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Celecoxibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cobimetinibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Copanlisibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fruquintinibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gefitinibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Guadecitabinesmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Immunotherapy 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipilimumab/Nivolumab Regimen 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lapatinibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Linifanibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Onatasertibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pasireotideother 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pazopanibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Peginterferon Alfa-2bother 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Refametinibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sacituzumab Govitecanadc 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sonidegibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Temozolomidesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tepotinibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trastuzumabmonoclonal antibody 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Veliparibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vincristinesmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Abemaciclibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Abirateronesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Adavosertibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Adjuvant Chemotherapy 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Afatinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Afliberceptother 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Amivantamabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Azathioprinesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Belinostatsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Capivasertibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carfilzomibother 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cemiplimabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Crizotinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dabrafenibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Denosumabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dostarlimabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dovitinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Enasidenibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Enfortumab Vedotinadc 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erdafitinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Eribulinsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Exemestanesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fexagratinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | FGFR4 Inhibitor H3B-6527 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Filgrastimother 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fisogatinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Foretinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Futibatinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ganetespibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Immunomodulatory Oligonucleotide 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Infigratinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Interferon Alfacon-1other 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipatasertibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Larotrectinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Linsitinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Melphalansmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | MTOR Kinase Inhibitor AZD8055 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Onartuzumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Osimertinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | PD-L1 Inhibitor 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Peginterferon Alfa-2aother 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pertuzumabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Platinum Doublet 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Porfimer 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pralsetinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Retifanlimabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ribociclibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ropeginterferon Alfa-2bother 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Selumetinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Talimogene Laherparepvecgene therapy 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tamibarotenesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Taselisibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tazemetostatsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trastuzumab Emtansineadc 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tyrosine Kinase Inhibitor 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vandetanibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vismodegibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Zoledronic Acidsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Liver Carcinoma | 1 | Observed | clinicaltrials | graph → |